Touchstone International Medical Science Co., Ltd. (688013.SS)
CNY 18.61
(-0.59%)
CNY 18.61
(-0.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 55.08 Million CNY | 57.18% |
| 2022 | 35.04 Million CNY | 7.15% |
| 2021 | 32.7 Million CNY | 69.03% |
| 2020 | 19.35 Million CNY | 9.19% |
| 2019 | 17.72 Million CNY | -47.96% |
| 2018 | 34.05 Million CNY | 81.85% |
| 2017 | 18.72 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 50.76 Million CNY | 7.29% |
| 2024 Q3 | 100 Million CNY | 96.97% |
| 2024 Q1 | 47.31 Million CNY | -14.1% |
| 2023 Q2 | 34.72 Million CNY | -12.79% |
| 2023 FY | 55.08 Million CNY | 57.18% |
| 2023 Q4 | 55.08 Million CNY | 56.09% |
| 2023 Q3 | 35.29 Million CNY | 1.64% |
| 2023 Q1 | 39.81 Million CNY | 13.61% |
| 2022 Q3 | 57.08 Million CNY | 15.71% |
| 2022 Q2 | 49.33 Million CNY | 58.88% |
| 2022 Q1 | 31.05 Million CNY | -5.06% |
| 2022 FY | 35.04 Million CNY | 7.15% |
| 2022 Q4 | 35.04 Million CNY | -38.61% |
| 2021 Q3 | 27.93 Million CNY | 12.32% |
| 2021 Q1 | 25.69 Million CNY | 32.79% |
| 2021 Q2 | 24.86 Million CNY | -3.22% |
| 2021 Q4 | 32.7 Million CNY | 17.1% |
| 2021 FY | 32.7 Million CNY | 69.03% |
| 2020 Q3 | 26.38 Million CNY | 47.39% |
| 2020 Q4 | 19.35 Million CNY | -26.67% |
| 2020 Q2 | 17.9 Million CNY | 19.67% |
| 2020 Q1 | 14.96 Million CNY | -15.58% |
| 2020 FY | 19.35 Million CNY | 9.19% |
| 2019 FY | 17.72 Million CNY | -47.96% |
| 2019 Q4 | 17.72 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 34.05 Million CNY | 81.85% |
| 2017 FY | 18.72 Million CNY | 0.0% |